These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17721635)

  • 1. Retinal central artery occlusion in a young woman after ten days of a drospirenone-containing oral contraceptive (Yasmin).
    Girolami A; Vettore S; Tezza F; Girolami B
    Thromb Haemost; 2007 Aug; 98(2):473-4. PubMed ID: 17721635
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
    Oelkers W
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():17-24. PubMed ID: 11246598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction associated with Yasmin oral contraceptive.
    Ortí G; Mira Y; Vaya A
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):336-7. PubMed ID: 17636199
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety profile of Yasmin is similar to other combined oral contraceptives.
    Cronin M; Korner P
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):245-6. PubMed ID: 18372279
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral contraceptive-induced central retinal artery occlusion.
    Rekhi GS; Dheer S
    J Assoc Physicians India; 2002 Aug; 50():1084-5. PubMed ID: 12421041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yasmin--a new oral contraceptive, a new progestogen: the reasons why.
    Mansour D
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():9-16. PubMed ID: 11246601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
    Somma MA
    Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
    [No Abstract]   [Full Text] [Related]  

  • 9. Is [symbol: see text] Yasmin a "truly different" pill?
    Drug Ther Bull; 2002 Aug; 40(8):57-9. PubMed ID: 12216337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial infarction in a young female smoker taking oral contraception].
    Cabou C; Lacroix I; Roncalli J; Elbaz M; Caillaux D; Damase-Michel C; Fauvel JM; Montastruc JL
    Arch Mal Coeur Vaiss; 2006 Jan; 99(1):80-5. PubMed ID: 16479896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central retinal artery occlusion and oral contraceptives.
    Mehta C
    Indian J Ophthalmol; 1999 Mar; 47(1):35-6. PubMed ID: 16130283
    [No Abstract]   [Full Text] [Related]  

  • 12. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
    Oranratanaphan S; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S17-22. PubMed ID: 17726807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yasmin--an oral contraceptive with a new progestin.
    Med Lett Drugs Ther; 2002 Jun; 44(1133):55-7. PubMed ID: 12080274
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives and venous thromboembolism: old questions revisited.
    Dinger J
    J Fam Plann Reprod Health Care; 2009 Oct; 35(4):211-3. PubMed ID: 19849911
    [No Abstract]   [Full Text] [Related]  

  • 16. Drospirenone (Slynd) - a new progestin-only oral contraceptive.
    Med Lett Drugs Ther; 2020 Feb; 62(1591):18-19. PubMed ID: 32022787
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen.
    Hernádi L; Marr J; Trummer D; De Leo V; Petraglia F
    Contraception; 2009 Jul; 80(1):18-24. PubMed ID: 19501211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
    Oelkers W
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():19-26; discussion 42-3. PubMed ID: 12659403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive postoperative pulmonary embolism in a young woman using oral contraceptives: the value of a preoperative anesthetic consult.
    Amar S; Van Boven M; Rooijakkers H; Momeni M
    Acta Anaesthesiol Belg; 2014; 65(2):73-5. PubMed ID: 25223166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.